COGNEX 40 (Cognex 40 mg)
Generic Name: tacrine
Pill imprint COGNEX 40 has been identified as Cognex 40 mg.
Cognex is used in the treatment of alzheimer's disease; dementia and belongs to the drug class cholinesterase inhibitors. Risk cannot be ruled out during pregnancy. Cognex 40 mg is not a controlled substance under the Controlled Substance Act (CSA).
Cognex
- Generic Name:
- tacrine
- Imprint:
- COGNEX 40
- Strength:
- 40 mg
- Color:
- Purple / Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Cholinesterase inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- First Horizon Pharmaceutical Corporation
- National Drug Code (NDC):
- 59630-0193
More about Cognex (tacrine)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: cholinesterase inhibitors
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
